1
|
van Vroonhoven ECN, Picavet LW, Scholman RC, Sijbers LJPM, Kievit CRE, van den Dungen NAM, Mokry M, Evers A, Lebbink RJ, Mocholi E, Coffer PJ, Calis JJA, Vastert SJ, van Loosdregt J. N6-Methyladenosine Promotes TNF mRNA Degradation In CD4+ T Lymphocytes. J Leukoc Biol 2024:qiae087. [PMID: 38657004 DOI: 10.1093/jleuko/qiae087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 03/12/2024] [Accepted: 03/20/2024] [Indexed: 04/26/2024] Open
Abstract
N6-methyladenosine (m6A) is a RNA modification that can regulate post-transcriptional processes including RNA stability, translation, splicing and nuclear export. In CD4+ lymphocytes, m6A modifications have been demonstrated to play a role in early differentiation processes. The role of m6A in CD4+ T cell activation and effector function remains incompletely understood. To assess the role of m6A in CD4+ T lymphocyte activation and function, we assessed the transcriptome-wide m6A landscape of human primary CD4+ T cells by methylated RNA immunoprecipitation (meRIP) sequencing. Stimulation of the T cells impacted the m6A pattern of hundreds of transcripts including tumor necrosis factor (TNF). m6A methylation was increased on TNF mRNA after activation, predominantly in the 3' untranslated region (UTR) of the transcript. Manipulation of m6A levels in primary human T cells, the directly affected the expression of TNF. Furthermore, we identified that the m6A reader protein YT521-B homology domain family-2 (YTHDF2) binds m6A-methylated TNF mRNA, and promotes its degradation. Taken together, this study demonstrates that TNF expression in CD4+ T lymphocytes is regulated via m6A and YTHDF2, thereby providing novel insight into the regulation of T cell effector functions.
Collapse
Affiliation(s)
- Ellen C N van Vroonhoven
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Lucas W Picavet
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Rianne C Scholman
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Lyanne J P M Sijbers
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Corlinda R E Kievit
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| | | | - Michal Mokry
- Department of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Anouk Evers
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Robert J Lebbink
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Enric Mocholi
- Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands
- Regenerative Medicine Center, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Paul J Coffer
- Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands
- Regenerative Medicine Center, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Jorg J A Calis
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Sebastiaan J Vastert
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
- Department of Pediatric Rheumatology and Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Jorg van Loosdregt
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
| |
Collapse
|
2
|
Langedijk AC, Vrancken B, Lebbink RJ, Wilkins D, Kelly EJ, Baraldi E, Mascareñas de Los Santos AH, Danilenko DM, Choi EH, Palomino MA, Chi H, Keller C, Cohen R, Papenburg J, Pernica J, Greenough A, Richmond P, Martinón-Torres F, Heikkinen T, Stein RT, Hosoya M, Nunes MC, Verwey C, Evers A, Kragten-Tabatabaie L, Suchard MA, Kosakovsky Pond SL, Poletto C, Colizza V, Lemey P, Bont LJ. The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus. Nat Commun 2024; 15:3083. [PMID: 38600104 PMCID: PMC11006891 DOI: 10.1038/s41467-024-47118-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Accepted: 03/14/2024] [Indexed: 04/12/2024] Open
Abstract
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in young children and the second leading cause of infant death worldwide. While global circulation has been extensively studied for respiratory viruses such as seasonal influenza, and more recently also in great detail for SARS-CoV-2, a lack of global multi-annual sampling of complete RSV genomes limits our understanding of RSV molecular epidemiology. Here, we capitalise on the genomic surveillance by the INFORM-RSV study and apply phylodynamic approaches to uncover how selection and neutral epidemiological processes shape RSV diversity. Using complete viral genome sequences, we show similar patterns of site-specific diversifying selection among RSVA and RSVB and recover the imprint of non-neutral epidemic processes on their genealogies. Using a phylogeographic approach, we provide evidence for air travel governing the global patterns of RSVA and RSVB spread, which results in a considerable degree of phylogenetic mixing across countries. Our findings highlight the potential of systematic global RSV genomic surveillance for transforming our understanding of global RSV spread.
Collapse
Affiliation(s)
- Annefleur C Langedijk
- Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Lundlaan 6, 3584 EA, Utrecht, the Netherlands
| | - Bram Vrancken
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Herestraat 49, 3000, Leuven, Belgium
- Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, Bruxelles, Belgium
| | - Robert Jan Lebbink
- Department of Medical Microbiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
| | - Deidre Wilkins
- Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, 1 MedImmune Way, Gaithersburg, MD, USA
| | - Elizabeth J Kelly
- Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, 1 MedImmune Way, Gaithersburg, MD, USA
| | - Eugenio Baraldi
- Department of Woman's and Child's Health, University Hospital of Padova, Padova, Italy
- ReSViNET Foundation, Zeist, the Netherlands
- Institute of Pediatric Research "Città della Speranza", Padova, Italy
| | | | - Daria M Danilenko
- Smorodintsev Research Institute of Influenza, St. Petersburg, Russia
| | - Eun Hwa Choi
- Seoul National University Children's Hospital, Seoul, South Korea
| | | | - Hsin Chi
- MacKay Children's Hospital, New Taipei, Taiwan, ROC
| | - Christian Keller
- Institute of Virology, University Hospital Giessen and Marburg, Marburg, Germany
| | | | | | | | - Anne Greenough
- ReSViNET Foundation, Zeist, the Netherlands
- King's College London, London, UK
| | | | - Federico Martinón-Torres
- ReSViNET Foundation, Zeist, the Netherlands
- Hospital Clínico Universitario de Santiago, Galicia, Spain
| | - Terho Heikkinen
- ReSViNET Foundation, Zeist, the Netherlands
- University of Turku and Turku University Hospital, Turku, Finland
| | - Renato T Stein
- ReSViNET Foundation, Zeist, the Netherlands
- Pontificia Universidade Catolica de Rio Grande do Sul, Porto Alegre, Brazil
| | - Mitsuaki Hosoya
- Fukushima Medical University School of Medicine, Fukushima, Japan
| | - Marta C Nunes
- ReSViNET Foundation, Zeist, the Netherlands
- Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- South African Medical Research Council, Vaccines & Infectious Diseases Analytics Research Unit, and Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Charl Verwey
- Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- Hospices Civils de Lyon and the Centre International de Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, Lyon, France
| | - Anouk Evers
- Department of Medical Microbiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
| | | | - Marc A Suchard
- Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA
- Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, 90095, USA
- Department of Biomathematics, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA
| | - Sergei L Kosakovsky Pond
- Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, 801 N Broad St, Philadelphia, PA, 19122, USA
| | - Chiara Poletto
- INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, F75012, Paris, France
| | - Vittoria Colizza
- INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, F75012, Paris, France
| | - Philippe Lemey
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Herestraat 49, 3000, Leuven, Belgium
| | - Louis J Bont
- Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Lundlaan 6, 3584 EA, Utrecht, the Netherlands.
- ReSViNET Foundation, Zeist, the Netherlands.
| |
Collapse
|
3
|
Langedijk AC, Vrancken B, Lebbink RJ, Evers A, Pieciak RC, Lemey P, Bont LJ, Gill CJ. Lethal Respiratory Syncytial Virus in Zambia Is Sensitive to Long-acting Monoclonal Antibodies. Pediatr Infect Dis J 2023; 42:e421-e423. [PMID: 37523582 DOI: 10.1097/inf.0000000000004031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 08/02/2023]
Affiliation(s)
- Annefleur C Langedijk
- Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands
| | - Bram Vrancken
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium, Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, Bruxelles, Belgium
| | - Robert Jan Lebbink
- Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, the Netherlands
| | - Anouk Evers
- Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, the Netherlands
| | - Rachel C Pieciak
- Department of Global Health, Boston University School of Public Health, Boston, Massachusetts
| | - Philippe Lemey
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
| | - Louis J Bont
- Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands
| | - Christopher J Gill
- Department of Global Health, Boston University School of Public Health, Boston, Massachusetts
| |
Collapse
|
4
|
van Vroonhoven ECN, Picavet LW, Scholman RC, van den Dungen NAM, Mokry M, Evers A, Lebbink RJ, Calis JJA, Vastert SJ, van Loosdregt J. N 6-Methyladenosine Directly Regulates CD40L Expression in CD4 + T Lymphocytes. Biology (Basel) 2023; 12:1004. [PMID: 37508433 PMCID: PMC10376055 DOI: 10.3390/biology12071004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Revised: 06/29/2023] [Accepted: 07/05/2023] [Indexed: 07/30/2023]
Abstract
T cell activation is a highly regulated process, modulated via the expression of various immune regulatory proteins including cytokines, surface receptors and co-stimulatory proteins. N6-methyladenosine (m6A) is an RNA modification that can directly regulate RNA expression levels and it is associated with various biological processes. However, the function of m6A in T cell activation remains incompletely understood. We identify m6A as a novel regulator of the expression of the CD40 ligand (CD40L) in human CD4+ lymphocytes. Manipulation of the m6A 'eraser' fat mass and obesity-associated protein (FTO) and m6A 'writer' protein methyltransferase-like 3 (METTL3) directly affects the expression of CD40L. The m6A 'reader' protein YT521-B homology domain family-2 (YTHDF2) is hypothesized to be able to recognize and bind m6A specific sequences on the CD40L mRNA and promotes its degradation. This study demonstrates that CD40L expression in human primary CD4+ T lymphocytes is regulated via m6A modifications, elucidating a new regulatory mechanism in CD4+ T cell activation that could possibly be leveraged in the future to modulate T cell responses in patients with immune-related diseases.
Collapse
Affiliation(s)
- Ellen C N van Vroonhoven
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Lucas W Picavet
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Rianne C Scholman
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Noortje A M van den Dungen
- Department of Experimental Cardiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Michal Mokry
- Department of Experimental Cardiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Anouk Evers
- Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Robert J Lebbink
- Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Jorg J A Calis
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Sebastiaan J Vastert
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
- Department of Pediatric Rheumatology and Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| | - Jorg van Loosdregt
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
| |
Collapse
|
5
|
Ijzerman R, Janssen V, Van Der Vaart R, Van Den Broek I, Dusseldorp E, Kraaijenhagen R, Reijnders T, Scholte Op Reimer W, Evers A. Goal setting within cardiac care: the effect of linking life goals to health goals on intention to change lifestyle in patients. Eur J Prev Cardiol 2022. [DOI: 10.1093/eurjpc/zwac056.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Dutch Heart Foundation and ZonMw
Goal setting within cardiac care: the effect of linking life goals to health goals on intention to change lifestyle in patients.
Background
Initiating and maintaining a healthy lifestyle is difficult and often needs several attempts. Reaching health goals may become easier if linked to life goals (see Fig.1). Life goals, also described as abstract, long-term goals, reflect objectives that matter to people personally. Guidelines recommend goal setting to realise behaviour change in patients with cardiovascular disease (CVD). However, research is inconclusive about whether positive effects of lifestyle interventions can be attributed to linking life goals to health goals or to other intervention elements.
Purpose
This experimental study examines the effect of linking a life goal to a health goal on intention to change lifestyle in patients with CVD.
Methods
Research panel members of a CVD patient association were recruited for the online study via advertisement on the association’s website. Patients were randomised and controlled into two groups: setting a health goal (HG) and setting a health goal linked to a life goal (+LG). Based on the Theory of Planned Behavior (see Fig.2) and previous research, main outcome measure ‘intention to change lifestyle’ was assessed using a visual analogue scale ranging 0-10 (low to high). Effect of group (HG vs +LG) on intention to change lifestyle (high vs low) was analysed using logistic regression. Gender, age, education level, and type of CVD were entered as possible effect modifiers.
Results
Patients (N=628) were mostly male (61%), with a mean age of 69±35 years, and medium (33%) or high (47%) education level. In both groups, HG and +LG, 47% of the patients expressed high intention to change lifestyle. Logistic regression showed no effect of group (HG vs +LG) on intention, OR:0.98 (95%CI: 0.72–1.35, p=0.92). Only education level appeared to be an effect modifier, X²(2):8.2, p=0.02; showing that linking a life goal to a health goal was effective in patients with a high education level. Contrary to this, setting a life goal negatively affected intention in patients with a low education level. Among patients with a high education level, percentage of 'high intention' was higher in the +LG group (57%) than in the HG group (45%). In contrast, among patients with a low education level, percentage of 'high intention' was higher in the HG group (48%) than in the +LG group (36%).
Conclusions
This study showed no main effect of linking a life goal to a health goal on patients’ intention to change lifestyle. Education level was found to be a significant effect modifier. Patients with a high education level significantly benefitted from linking a life goal to a health goal. Patients with lower education levels benefitted most from setting only a health goal. In conclusion, within practice, health care providers may personalise their approach towards goal setting based on patients’ education level.
Collapse
Affiliation(s)
- R Ijzerman
- Leiden University, Department of Health, Medical and Neuropsychology, Leiden, Netherlands (The)
| | - V Janssen
- Leiden University Medical Center, Department of Cardiology, Leiden, Netherlands (The)
| | - R Van Der Vaart
- Leiden University, Department of Health, Medical and Neuropsychology, Leiden, Netherlands (The)
| | | | - E Dusseldorp
- Leiden University, Department of Methodology and Statistics of the Institute of Psychology, Leiden, Netherlands (The)
| | | | - T Reijnders
- Leiden University, Department of Health, Medical and Neuropsychology, Leiden, Netherlands (The)
| | - W Scholte Op Reimer
- Amsterdam UMC - Location Academic Medical Center, Department of Cardiology, Amsterdam, Netherlands (The)
| | - A Evers
- Leiden University, Department of Health, Medical and Neuropsychology, Leiden, Netherlands (The)
| |
Collapse
|
6
|
Evers A. Questionnaire use depends on the study goal, target group and phase of the condition. Br J Dermatol 2022; 186:395-396. [PMID: 35224722 PMCID: PMC9414339 DOI: 10.1111/bjd.20948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Linked Article: Szabó et al. Br J Dermatol 2022; 186:485–495.
Collapse
Affiliation(s)
- A. Evers
- Leiden University – HealthMedical and Neuropsychology PO Box 9555 Leiden RB2300the Netherlands
| |
Collapse
|
7
|
Langedijk AC, Harding ER, Konya B, Vrancken B, Lebbink RJ, Evers A, Willemsen J, Lemey P, Bont LJ. A systematic review on global RSV genetic data: Identification of knowledge gaps. Rev Med Virol 2021; 32:e2284. [PMID: 34543489 PMCID: PMC9285027 DOI: 10.1002/rmv.2284] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2021] [Revised: 07/28/2021] [Accepted: 08/02/2021] [Indexed: 11/08/2022]
Abstract
Respiratory syncytial virus (RSV) is a major health problem. A better understanding of the geographical and temporal dynamics of RSV circulation will assist in tracking resistance against therapeutics currently under development. Since 2015, the field of RSV molecular epidemiology has evolved rapidly with around 20–30 published articles per year. The objective of this systematic review is to identify knowledge gaps in recent RSV genetic literature to guide global molecular epidemiology research. We included 78 studies published between 2015 and 2020 describing 12,998 RSV sequences of which 8,233 (63%) have been uploaded to GenBank. Seventeen (22%) studies were performed in low‐ and middle‐income countries (LMICs), and seven (9%) studies sequenced whole‐genomes. Although most reported polymorphisms for monoclonal antibodies in clinical development (nirsevimab, MK‐1654) have not been tested for resistance in neutralisation essays, known resistance was detected at low levels for the nirsevimab and palivizumab binding site. High resistance was found for the suptavumab binding site. We present the first literature review of an enormous amount of RSV genetic data. The need for global monitoring of RSV molecular epidemiology becomes increasingly important in evaluating the effectiveness of monoclonal antibody candidates as they reach their final stages of clinical development. We have identified the following three knowledge gaps: whole‐genome data to study global RSV evolution, data from LMICs and data from global surveillance programs.
Collapse
Affiliation(s)
- Annefleur C Langedijk
- Department of Paediatrics, Division of Paediatric Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Eline R Harding
- Department of Paediatrics, Division of Paediatric Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Burak Konya
- Department of Paediatrics, Division of Paediatric Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Bram Vrancken
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
| | - Robert Jan Lebbink
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Anouk Evers
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Joukje Willemsen
- Department of Paediatrics, Division of Paediatric Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Philippe Lemey
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
| | - Louis J Bont
- Department of Paediatrics, Division of Paediatric Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.,ReSViNET Foundation, Zeist, The Netherlands
| |
Collapse
|
8
|
Langedijk AC, Lebbink RJ, Naaktgeboren C, Evers A, Viveen MC, Greenough A, Heikkinen T, Stein RT, Richmond P, Martinón-Torres F, Nunes M, Hosoya M, Keller C, Bauck M, Cohen R, Papenburg J, Pernica J, Hennus MP, Jin H, Tabor DE, Tovchigrechko A, Ruzin A, Abram ME, Wilkins D, Wildenbeest JG, Kragten-Tabatabaie L, Coenjaerts FEJ, Esser MT, Bont LJ. Global molecular diversity of RSV - the "INFORM RSV" study. BMC Infect Dis 2020; 20:450. [PMID: 32591017 PMCID: PMC7316634 DOI: 10.1186/s12879-020-05175-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Accepted: 06/17/2020] [Indexed: 11/30/2022] Open
Abstract
Background Respiratory syncytial virus (RSV) is a global cause of severe respiratory morbidity and mortality in infants. While preventive and therapeutic interventions are being developed, including antivirals, vaccines and monoclonal antibodies, little is known about the global molecular epidemiology of RSV. INFORM is a prospective, multicenter, global clinical study performed by ReSViNET to investigate the worldwide molecular diversity of RSV isolates collected from children less than 5 years of age. Methods The INFORM study is performed in 17 countries spanning all inhabited continents and will provide insight into the molecular epidemiology of circulating RSV strains worldwide. Sequencing of > 4000 RSV-positive respiratory samples is planned to detect temporal and geographical molecular patterns on a molecular level over five consecutive years. Additionally, RSV will be cultured from a subset of samples to study the functional implications of specific mutations in the viral genome including viral fitness and susceptibility to different monoclonal antibodies. Discussion The sequencing and functional results will be used to investigate susceptibility and resistance to novel RSV preventive or therapeutic interventions. Finally, a repository of globally collected RSV strains and a database of RSV sequences will be created.
Collapse
Affiliation(s)
- Annefleur C Langedijk
- Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
| | - Robert Jan Lebbink
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Christiana Naaktgeboren
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Anouk Evers
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Marco C Viveen
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Anne Greenough
- Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.,ReSViNET foundation, Zeist, the Netherlands
| | - Terho Heikkinen
- ReSViNET foundation, Zeist, the Netherlands.,Department of Paediatrics, University of Turku and Turku University Hospital, Turku, Finland
| | - Renato T Stein
- Centro INFANT at Pontificia Universidade Catolica de Rio Grande do Sul, Porto Alegre, Brazil
| | - Peter Richmond
- Department of Paediatrics, The University of Queensland, Brisbane, Australia
| | | | - Marta Nunes
- ReSViNET foundation, Zeist, the Netherlands.,Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.,Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Mitsuaki Hosoya
- Department of Paediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - Christian Keller
- Department of Virology, University Hospital Giessen and Marburg, Marburg, Germany
| | - Monika Bauck
- Department of Paediatrics, University Hospital Giessen and Marburg, Marburg, Germany
| | - Robert Cohen
- Association Clinique et Thérapeutique Infantile du Val-de-Marne, CHI Créteil, GRC Gemini, Université Paris XII, Créteil, France
| | - Jesse Papenburg
- Department of Paediatrics, Division of Pediatric Infectious Diseases, Montreal Children's Hospital, McGill University Health Centre, Montreal, Canada
| | - Jeffrey Pernica
- Department of Paediatrics, McMaster University, Hamilton, Canada
| | - Marije P Hennus
- Paediatric Intensive Care Unit, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
| | - Hong Jin
- AstraZeneca, Gaithersburg/South San Francisco, USA
| | | | | | - Alexey Ruzin
- AstraZeneca, Gaithersburg/South San Francisco, USA
| | | | | | - Joanne G Wildenbeest
- Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
| | | | - Frank E J Coenjaerts
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Mark T Esser
- AstraZeneca, Gaithersburg/South San Francisco, USA
| | - Louis J Bont
- Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands. .,ReSViNET foundation, Zeist, the Netherlands.
| |
Collapse
|
9
|
Misery L, Brenaut E, Pereira M, Augustin M, Bobko S, Dalgard F, Evers A, Garcovich S, Gieler U, Gonçalo M, Halvorsen J, Lambert J, Legat F, Leslie T, Metz M, Reich A, Savk E, Serra-Baldrich E, Streit M, Szepietowski J, Weisshaar E, Ständer S. Consensus d’experts européens pour la définition, la classification et la terminologie du prurigo chronique. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
10
|
van der Kuil M, Evers A, Visser-Meily A, van der Ham I. Serious games in cognitive rehabilitation of spatial navigation impairment. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Meeuwis S, Middendorp H, Veldhuijzen D, Laarhoven A, Houwer J, Lavrijsen A, Evers A. Placebo Effects of Open-label Verbal Suggestions on Itch. Acta Derm Venereol 2018; 98:268-274. [DOI: 10.2340/00015555-2823] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
12
|
Laarhoven A, Ulrich D, Wilder-Smith O, Loey N, Nieuwenhuis M, Wee N, Evers A. Psychophysiological Processing of Itch in Patients with Chronic Post-burn Itch: An Exploratory Study. Acta Derm Venereol 2016; 96:613-8. [DOI: 10.2340/00015555-2323] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
13
|
Zuidema R, van Gaal B, Repping-Wuts H, Evers A, van Achterberg T. THU0582-HPR What is Known about Rheumatoid Arthritis Patients' Support Needs for Self-Management? A Scoping Review. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.4222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
14
|
van Duijn H, Ferwerda M, Tomas M, van Middendorp H, Ros H, Evers A. OP0263-PARE Patient Involvement in E-Health Research and Intervention Development. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
15
|
Ferwerda M, Spillekom S, van Middendorp H, van Beugen S, Kievit W, Fransen J, Visser H, van Oijen P, Taal E, van Riel P, de Jong E, van de Kerkhof P, van der Laar M, Evers A. THU0590 The Patient-Therapist Relationship as An Indicator for Treatment Success in E-Health Treatments for Patients with Rheumatoid Arthritis and Psorias. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
16
|
Ständer S, Blome C, Breil B, Bruland P, Darsow U, Dugas M, Evers A, Fritz F, Metz M, Phan NQ, Raap U, Reich A, Schneider G, Steinke S, Szepietowski J, Weisshaar E, Augustin M. [Assessment of pruritus - current standards and implications for clinical practice : consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)]. Hautarzt 2012; 63:521-2, 524-31. [PMID: 22733240 DOI: 10.1007/s00105-011-2318-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
With a prevalence of 20%, chronic pruritus is a symptom of many diseases with major impact on healthcare costs. The lack of specific therapeutic measures makes the development of new drugs and their testing in clinical trials urgent. It is not possible to measure pruritus in an objective way. For these reasons, it is necessary to have a series of standardized measures to characterize pruritus in a reliable way. Intensity scales such as the visual analog scale (VAS) are most frequently used to document the course of the symptoms. However, for assessing pruritus intensity, VAS is not an optimal instrument, although it cannot be dispensed with. The VAS should be combined with other scales in clinical studies in order to internally test the consistency of data. Other instruments for assessing intensity and course of pruritus are in the process of development. Presently scratch activity and scratch-associated lesions can be documented in a descriptive fashion. There are some studies that have employed devices to document scratch activity; however, methodological studies are not yet available. The patient-benefit index is an indispensable tool in clinical trials. A questionnaire for gathering data on the history and some pruritus-specific parameters has been developed and published. Questionnaires on patient quality of life, anxiety and depression are helpful in obtaining data on other cost-relevant parameters. A questionnaire on the quality of life, for instance, can provide important help in the assessment of the burden of the disease. The results of these questionnaires can be correlated with data on pruritus intensity scales. The relevant questionnaires have been partially digitalized so that they are available immediately as part of patient care. Additional methodological developments and studies are required in order to define a robust set of instruments for measuring pruritus in daily practice and in clinical studies.
Collapse
Affiliation(s)
- S Ständer
- Klinik für Hautkrankheiten und Kompetenzzentrum Chronischer Pruritus, Universitätsklinikum Münster, Deutschland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Atanasova S, Evers A, Fuchs G, Petri K, Obert M, Fischer-Heuschkel A, Rabin L, Hirschburger M, Padberg W, Grau V. A new experimental model for chronic lung allograft damage. Pneumologie 2012. [DOI: 10.1055/s-0032-1315547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Van den Boogaard M, Schoonhoven L, Evers A, Van der Hoeven J, Van Achterberg TH, Pickkers P. Impact of delirium in critically ill patients on long-term health-related quality of life and cognitive functioning. Crit Care 2011. [PMCID: PMC3067012 DOI: 10.1186/cc9758] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
19
|
Ozyemisci-Taskiran O, Gunendi Z, Beyazova M, Gunendi Z, Erden Z, Zinnuroglu M, Gogus F, Cevik FC, Yazici S, Cil H, Cevik R, Sarac AJ, Nas K, Park W, Lim MJ, Kwon SR, Yoon JY, Ju GE, Son MJ, Coskun O, Paker N, Bugdayci D, Santos-Moreno P, Cubides MF, Guzman C, Reyes E, Londono J, Valle-Onate R, Zateri C, Kilinc S, Birtane M, Tastekin N, Sabirli F, Paker N, Bugdayci D, Turan Y, Kocaaga Z, Karakoyun-Celik O, Gurgan A, Duransoy A, Filipescu I, Pamfil C, Dumitru B, Garboan I, Rednic S, Bugdayci D, Paker N, Altunalan A, Sahin M, Dere D, Cidem M, Capkin E, Karkucak M, Karaca A, Capkin E, Karkucak M, Akyuz A, Alver A, Turkyilmaz AK, Zengin E, Capkin E, Karkucak M, Akyuz A, Alver A, Ulusoy H, Karaca A, Kesikburun S, Aydemir K, Gunendi Z, Ozgul A, Sezer N, Koseoglu F, Sutbeyaz ST, Oken O, Ozlemis B, Kibar S, Yurdakul S, Findikoglu SY, Hatemi G, Suzen S, Yazici H, Haroon M, Adeeb F, Devlin J, Gradaigh DO, Walker F, Odabasi BB, Sendur OF, Turan Y, Moghimi N, Nadrian H, Moradzadeh R, Nadrian E, Rahimi E, Ediz L, Hiz O, Fethi Ceylan M, Toprak M, Tekeoglu I, Hatemi G, Hamuryudan V, Tascilar K, Ugurlu S, Yazici H, Figen A, Pinar B, Figen T, Ataman S, Emlakcioglu E, Kaymak B, Ozcakar L, Tan AA, de Brouwer S, Kraaimaat F, Sweep F, Donders R, Eijsbouts A, Radstake T, van Riel P, Evers A, Cengiz K, Ilhanli I, Durmus D, Alayli G, Karakoc M, Batmaz I, Tahtasiz M, Nas K, Cevik R, Tekbas E, Yildiz I. Thematic stream: co-morbidity (PP59-PP86): PP59. A Single Dose of Indomethacin does not Prolong Premotor Reaction Time in Young Healthy Adults: A Randomised, Placebo Controlled, Double-Blind, Cross-Over Study. Rheumatology (Oxford) 2011. [DOI: 10.1093/rheumatology/ker099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Klusmann V, Evers A, Schwarzer R, Schlattmann P, Reischies FM, Heuser I, Dimeo FC. Complex Mental and Physical Activity in Older Women and Cognitive Performance: A 6-month Randomized Controlled Trial. J Gerontol A Biol Sci Med Sci 2010; 65:680-8. [DOI: 10.1093/gerona/glq053] [Citation(s) in RCA: 134] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
|
21
|
Kofahl C, Rink A, Evers A. Gesundheitskompetenz von türkischstämmigen Diabetikern. Gesundheitswesen 2009. [DOI: 10.1055/s-0029-1239196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
22
|
Lauwerier E, Crombez G, Damme S, Goubert L, Evers A. 967 CONSTRUCT VALIDITY OF THE ILLNESS COGNITION QUESTIONNAIRE: ROBUSTNESS OF THREE‐FACTOR STRUCTURE ACROSS PATIENTS WITH CHRONIC PAIN AND CHRONIC FATIGUE. Eur J Pain 2009. [DOI: 10.1016/s1090-3801(09)60970-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
| | | | - S. Damme
- Ghent University, Ghent, Belgium
| | | | - A. Evers
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
| |
Collapse
|
23
|
Leeuwen M, Rijswijk E, Wolff A, Zentjens W, Evers A. 472 EARLY IDENTIFICATION OF HIGH‐RISK PATIENTS FOR CHRONIC BACK PROBLEMS IN PRIMARY CARE. Eur J Pain 2009. [DOI: 10.1016/s1090-3801(09)60475-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- M. Leeuwen
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
| | - E. Rijswijk
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
| | - A. Wolff
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
| | - W. Zentjens
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
| | - A. Evers
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
| |
Collapse
|
24
|
Kofahl C, Rink A, Evers A. Gesundheitskompetenz von türkischstämmigen Diabetikern. DIABETOL STOFFWECHS 2009. [DOI: 10.1055/s-0029-1221898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
Haisch A, Evers A, Jöhrens-Leder K, Jovanovic S, Sedlmaier B, Scherer H, Probst J, Glaubitt W. In vitro- / in vivo- Untersuchungen zur Biokompatibilität und Bioresorption amorpher Kieselgelfaser für das Tissue engineering humaner Knorpelgewebe. Laryngorhinootologie 2004. [DOI: 10.1055/s-2004-823584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
26
|
Barnewitz D, Evers A, Zimmermann J, Wilke I, Kaps C, Sittinger M. [Tissue engineering: new treatment of cartilage alterations in degenerative joint diseases in horses--preliminary results of a long term study]. Berl Munch Tierarztl Wochenschr 2003; 116:157-61. [PMID: 12680284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
Degenerative alterations in fetlock joints of the forelimb are common diagnoses for horses. The hyaline cartilage has a low capacity to regenerate and the treatment by veterinarians is often insufficient. As a final result, horses with articular cartilage defects are often not able to take part in competitions anymore. To establish an autologous cartilage repair method, we set artificial lesions (8 mm in diameter) into the fetlock joints of the forelimb of three horses. These defects were closed with autologous chondrocyte implants, which were fixed with titan-suture-anchors. After 3, 12 and 24 months, biopsies were taken by arthroscopy. One horse was euthanized after 9, another one after 24 months. The repair tissue was examined histologically and by biochemical analysis of hydroxyproline and glycosaminoglycan, which are typical cartilage related substances. After 9 months, the integration of the implant into native cartilage was demonstrated by electron microscopy. After 24 months, histological staining showed a similar morphology of the cartilage repair tissue compared with the surrounding native cartilage. Biochemical analysis of typical cartilage matrix molecules revealed formation of hyaline-like cartilage within tissue engineered autologous chondrocyte transplants.
Collapse
Affiliation(s)
- D Barnewitz
- Forschungszentrum für Medizintechnik und Biotechnologie e.V. (FZMB), Bad Langensalza.
| | | | | | | | | | | |
Collapse
|
27
|
van der Werf SP, Evers A, Jongen PJH, Bleijenberg G. The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis. Mult Scler 2003; 9:89-94. [PMID: 12617274 DOI: 10.1191/1352458503ms854oa] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The aim of this study was to test, in patients with multiple sclerosis (MS), whether the concept of helplessness might improve the understanding of the relationship between disease severity (neurological impairment) and personality characteristics (emotional instability) on one hand, and depressive mood and fatigue severity on the other hand. Data pertain to 89 patients with a definite diagnosis of MS (Expanded Disability Status Scale [EDSS] ratings: 1-8). Helplessness, fatigue severity, depressive mood and emotional instability were rated with validated questionnaires. Model testing revealed that more neurological impairment and more emotional instability were associated with more helplessness, while higher levels of helplessness were associated with more fatigue and depressive mood. The initially observed direct relationship between EDSS and fatigue disappeared. Emotional instability also had a direct significant relationship with depressive mood, and depressive mood had only a small relationship with fatigue severity. The results indicated that helplessness affected both depressive mood and fatigue severity and that fatigue was not merely a symptom of depressive mood. The correlation between neurological impairment and fatigue severity was largely explained by the mediating effect of helplessness. These findings suggest that MS patients troubled by disabling fatigue might benefit from a psychological intervention targeting unfavourable illness cognitions.
Collapse
Affiliation(s)
- S P van der Werf
- Department of Medical Psychology, University Medical Centre Nijmegen, Nijmegen, The Netherlands.
| | | | | | | |
Collapse
|
28
|
|
29
|
Abstract
The PACHIQ (Parent-Child Interaction Questionnaire) is designed to help clinicians and researchers assess how parents view relationship with their children (PACHIQ-Parent version), and how children evaluate their relationship with their parents (PACHIQ-Child version). The items in this questionnaire refer to both interpersonal behavior and feelings. Conceptually, the PACHIQ is based on learning theory and structural systems theory. The development of the PACHIQ was described by Lange, Blonk and Wiers (1998). The present article reports additional psychometric data obtained in the development and validation of a revised, shorter version of the questionnaire (PACHIQ-R). We present norm tables for families with children who are referred for psychological treatment, and norm tables for families in the normal Dutch population. The PACHIQ-R displays a two-factor structure with factors interpreted as Conflict Resolution and Acceptance. The parent version of the PACHIQ-R contains 21 items, the child version 25 items.
Collapse
Affiliation(s)
- Alfred Lange
- Department of Psychology, University of Amsterdam, Roetersstraat 15, 1018 WB Amsterdam, The Netherlands.
| | | | | | | |
Collapse
|
30
|
Eger EI, Fisher DM, Dilger JP, Sonner JM, Evers A, Franks NP, Harris RA, Kendig JJ, Lieb WR, Yamakura T. Relevant concentrations of inhaled anesthetics for in vitro studies of anesthetic mechanisms. Anesthesiology 2001; 94:915-21. [PMID: 11388545 DOI: 10.1097/00000542-200105000-00032] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- E I Eger
- Department of Anesthesia and Perioperative Care, University of California, San Francisco 94143-0464, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Evers A. The new Long-Term Care Insurance Program in Germany. J Aging Soc Policy 1997; 10:77-98. [PMID: 10186771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
The article describes the new Long-Term Care Insurance Program (LTCI), which has been operational in Germany since 1995, as well as the policy issues leading to its enactment. After discussing similarities and differences with the traditional German social insurance-centered welfare system and some of the major weaknesses of the new program, two issues are discussed in more detail: (1) entitlement criteria and reimbursement rules and the ways they influence the conditions and quality of the professional care delivered; (2) the impact of cash as an alternative choice to services. The descriptive and evaluative sections use existing materials and reports; the second section is based, in addition, on a pilot study by the author, which looks at the reasons why so many people entitled to LTCI choose the cash alternative.
Collapse
Affiliation(s)
- A Evers
- Justus Liebig Universität, Giessen, Germany
| |
Collapse
|
32
|
Holtrop W, Evers A. [Pig farmer and veterinarian: a separate pair]. Tijdschr Diergeneeskd 1997; 122:342. [PMID: 9381467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
33
|
Abstract
Specificity of vaginal pulse amplitude and vaginal blood volume in reaction to visual sexual stimuli was investigated by comparing responses to sexual, anxiety-inducing, sexually threatening, and neutral film excerpts. Subjective sexual arousal, body sensations, emotional experience, skin conductance, and heart rate were monitored along with the genital measures. Self-report data confirmed the generation of affective states as intended. Results demonstrated response specificity of vaginal vasocongestion to sexual stimuli. In terms of both convergent and divergent validity, vaginal pulse amplitude was the superior genital measure. Skin conductance discriminated among stimuli only to a small degree, whereas heart rate failed to discriminate among stimuli altogether.
Collapse
Affiliation(s)
- E Laan
- Department of Clinical Psychology, Universiteit van Amsterdam, The Netherlands
| | | | | |
Collapse
|
34
|
Abstract
Treatment of cultured cells with phospholipase C causes increased rates of hydrolysis of cellular phosphatidylcholine and increased rates of incorporation of choline into phosphatidylcholine. The fate of the diacylglycerol produced by the phospholipase C hydrolysis was examined in two cell lines, Chinese hamster ovary and HeLa. In the former cells, turnover of the glycerol moiety of phosphatidylcholine was not enhanced by phospholipase C treatment, indicating that the phospholipase C-generated diacylglycerol was recycled into new phosphatidylcholine. In HeLa cells, turnover of the glycerol backbone of phosphatidylcholine was enhanced by phospholipase C treatment, and the increased rate of turnover of the glycerol moiety was similar to that of the phosphate moiety. Thus, the fate of diacylglycerol generated at the plasma membrane was demonstrated to differ in these two cell lines. Incorporation of precursors of diacylglycerol into phosphatidylcholine was not enhanced by phospholipase C treatment in either cell line.
Collapse
|
35
|
Needleman P, Wyche A, Sprecher H, Elliott WJ, Evers A. A unique cardiac cytosolic acyltransferase with preferential selectivity for fatty acids that form cyclooxygenase/lipoxygenase metabolites and reverse essential fatty acid deficiency. Biochim Biophys Acta 1985; 836:267-73. [PMID: 3927984 DOI: 10.1016/0005-2760(85)90075-x] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The rabbit heart contains a cytosolic enzyme which selectively incorporates polyunsaturated fatty acids into phosphatidylcholine. This unique acyltransferase is selective for fatty acids, thus far tested, that are substrates for cyclooxygenase or lipoxygenase (i.e., arachidonic, eicosapentaenoic, linoleic and dihomo-gamma-linoleic acids) or which reverse the symptoms of essential fatty acid deficiency (columbinic acid). On the other hand, palmitic, oleic, 5,8,11-eicosatrienoic (n-9, Mead acid), and docosatetraenoic acid (n-6, adrenic acid) were not incorporated in phospholipids by the cytosolic acyltransferase. No such fatty acid selectivity was exhibited by the cytosolic acyl-CoA synthetase or by the acyltransferase activities present in cardiac microsomes and mitochondria.
Collapse
|
36
|
Abstract
Experiments have been performed to determine if fibroblasts from patients with Duchenne muscular dystrophy (DMD) are defective in a process of membrane repair. Normal and DMD fibroblasts were treated with phospholipase C from Clostridium perfringens to degrade plasma membrane phosphatidylcholine, and then phosphatidylcholine synthesis was measured as the incorporation of [3H] choline into lipid. Phosphatidylcholine synthesis was stimulated by phospholipase C treatment to a similar extent in normal and DMD fibroblasts. The activity of CTP: phosphocholine cytidylyltransferase, the enzyme regulating phosphatidylcholine synthesis in phospholipase C-treated mammalian cells, was also stimulated to the same extent in both cell types. The subcellular location of the cytidylyltransferase was changed by phospholipase C treatment from mostly cytosolic to mostly particulate in both normal and DMD fibroblasts. It appears, therefore, that at least one type of membrane repair system functions normally in DMD fibroblasts.
Collapse
|
37
|
Weissmann G, Collins T, Evers A, Dunham P. Membrane perturbation: studies employing a calcium-sensitive dye, arsenazo III, in liposomes. Proc Natl Acad Sci U S A 1976; 73:510-4. [PMID: 1061152 PMCID: PMC335939 DOI: 10.1073/pnas.73.2.510] [Citation(s) in RCA: 42] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
A metallochromic dye, arsenazo III [2,7-bis-(2-arsonophenylazo)-1,8-dihydroxynaphthalene-3,6-disulfonic acid], has been incorporated into the aquenous interspaces of multilamellar liposomes. multilamellar liposomes. Addition of Ca produced no shift in the absorbance spectrum of dye captured by liposomes, whereas disruption of liposomes by Triton X-100, followed by Ca, produced the spectrum chracteristic of the dye-Ca complex: evidence of latency. Addition of excess ethyleneglycol-bis(beta-aminoethyl ether)-N,N'-tetraacetic acid (EGTA) reversed the spectal shift. Differences between spectra obtained in this sequence yielded dye efflus. To measure Ca efflux, difference spectra (+/-EGTA) were obtained from cationic liposomes containing Ca after detergent lysis (sensitivity less than 10 mmol/ml). Since liposomes were impermeable either to dye or Ca until perturbed, it was possible to test a variety of membrane-active steroids (diethylstilbesterol, deoxycorticosterone, etiocholanolone) for their capacity to provoke dye efflux from liposomes; preincorporation of cortisol stablized liposomes against dye leak. Immunoglobulin-coated liposomes containing dye were taken up by phagocytes of Mustelus canis, and phagocytic vacuoles stained red-purple after ingestions. Liposomes containing the calcium-sensitive dye constitute a simple, accurate means for determining membrane perturbation and Ca fluxes; their uptake by cells or organelles remains to be exploited further.
Collapse
|
38
|
|
39
|
Hancock R, Finkelstein N, Evers A. Stabilities of the cyanide complexes of the monovalent group IB metal ions in aqueous solution. ACTA ACUST UNITED AC 1972. [DOI: 10.1016/0022-1902(72)80020-4] [Citation(s) in RCA: 39] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
40
|
Evers A. [Hazards of balneotherapy]. Internist (Berl) 1971; 12:286-90. [PMID: 4946379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
41
|
Wagner HH, Alexander K, Evers A. [Arteriographic studies in rheumatoid arthritis]. Fortschr Geb Rontgenstr Nuklearmed 1968; 108:368-75. [PMID: 5693115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
42
|
Wagner HH, Alexander K, Evers A. Arteriographische Untersuchungen bei rheumatoider Arthritis. ROFO-FORTSCHR RONTG 1968. [DOI: 10.1055/s-0029-1228343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
43
|
Evers A. [Problems of dosage in balneotherapy]. Munch Med Wochenschr 1967; 109:564-9. [PMID: 5631251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
44
|
Evers A. [Reaction of patients with inflammatory and non-inflammatory joint changes to therapy with a sulfur-sol thermal spring]. Z Rheumaforsch 1967; 26:73-8. [PMID: 5591150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
45
|
Evers A. [Balneotherapy and rheumatism]. Arch Phys Ther (Leipz) 1965; 17:149-56. [PMID: 5827428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
46
|
Bartelheimer EW, Doering P, Evers A, Hartmann F, Poliwoda H. Perkutane Schwefelaufnahme und Ausscheidung im Harn, untersucht an einem mit H2S35 markierten nat�rlichen Sulfidquellwasser. Naturwissenschaften 1957. [DOI: 10.1007/bf00629202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
47
|
Evers A. 150 Jahre Bad Nenndorf. Dtsch Med Wochenschr 1937. [DOI: 10.1055/s-0028-1121175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
48
|
Evers A. Balneotherapie der Hautleiden. Dtsch Med Wochenschr 1937. [DOI: 10.1055/s-0028-1121102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|